Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Topical imiquimod in the treatment of metastatic melanoma to skin.

× No keyword cloud information.

25 in total

1. Plasmacytoid dendritic cells lead the charge against tumors.

Authors: Sonia Jiménez-Baranda; Inês Pires Silva; Nina Bhardwaj
Journal: J Clin Invest Date: 2012-01-17 Impact factor: 14.808

Review 2. The role of topical immune response modifiers in skin cancer.

Authors: Courtney Woodmansee; Jessica Pillow; Robert B Skinner
Journal: Drugs Date: 2006 Impact factor: 9.546

Review 3. Toll-like receptors in tumor immunotherapy.

Authors: Chrystal M Paulos; Andrew Kaiser; Claudia Wrzesinski; Christian S Hinrichs; Lydie Cassard; Andrea Boni; Pawel Muranski; Luis Sanchez-Perez; Douglas C Palmer; Zhiya Yu; Paul A Antony; Luca Gattinoni; Steven A Rosenberg; Nicholas P Restifo
Journal: Clin Cancer Res Date: 2007-09-15 Impact factor: 12.531

Review 4. Isolated limb perfusion for malignant melanoma: systematic review on effectiveness and safety.

Authors: David Moreno-Ramirez; Luis de la Cruz-Merino; Lara Ferrandiz; Roman Villegas-Portero; Adoracion Nieto-Garcia
Journal: Oncologist Date: 2010-03-26

5. Imiquimod-induced CCR9 Ameliorates murine TNBS Colitis.

Authors: Ryoma Suzuki; Kyoko Katakura; Tatsuo Fujiwara; Naohiko Gunji; Hiroshi Watanabe; Hiromasa Ohira
Journal: Fukushima J Med Sci Date: 2016-11-10

Review 6. Targeting pattern recognition receptors in cancer immunotherapy.

Authors: Nadège Goutagny; Yann Estornes; Uzma Hasan; Serge Lebecque; Christophe Caux
Journal: Target Oncol Date: 2012-03-08 Impact factor: 4.493

7. Topical treatment of cutaneous metastases of malignant melanoma using combined imiquimod and 5-fluorouracil.

Authors: Valerie Florin; Eve Desmedt; Sophie Vercambre-Darras; Laurent Mortier
Journal: Invest New Drugs Date: 2011-07-13 Impact factor: 3.850

8. Toll-like receptors and cutaneous melanoma.

Authors: Ilaria Coati; Serena Miotto; Irene Zanetti; Mauro Alaibac
Journal: Oncol Lett Date: 2016-09-21 Impact factor: 2.967

9. Polyarginine induces an antitumor immune response through binding to toll-like receptor 4.

Authors: Yong Yang; Joy Wolfram; Xiaohong Fang; Haifa Shen; Mauro Ferrari
Journal: Small Date: 2013-12-10 Impact factor: 13.281

10. Effectiveness of imiquimod limited to dermal melanoma metastases, with simultaneous resistance of subcutaneous metastasis.

Authors: Kristin Turza; Lynn T Dengel; Rebecca C Harris; James W Patterson; Kevin White; William W Grosh; Craig L Slingluff
Journal: J Cutan Pathol Date: 2009-07-07 Impact factor: 1.587